BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26520198)

  • 1. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():64-70. PubMed ID: 26520198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The usefulness of fecal tests in colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2014 Sep; 37 Suppl 3():71-6. PubMed ID: 25294268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colonoscopy in the screening, follow-up and treatment of colorectal cancer and precursor lesions].
    Pellisé M
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():71-7. PubMed ID: 26520199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening.
    Bessa Caserras X
    Gastroenterol Hepatol; 2016 Sep; 39 Suppl 1():68-78. PubMed ID: 27888867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update.
    Cubiella J; Marzo-Castillejo M; Mascort-Roca JJ; Amador-Romero FJ; Bellas-Beceiro B; Clofent-Vilaplana J; Carballal S; Ferrándiz-Santos J; Gimeno-García AZ; Jover R; Mangas-Sanjuán C; Moreira L; Pellisè M; Quintero E; Rodríguez-Camacho E; Vega-Villaamil P;
    Gastroenterol Hepatol; 2018 Nov; 41(9):585-596. PubMed ID: 30245076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies].
    Burón A; Grau J; Andreu M; Augé JM; Guayta-Escolies R; Barau M; Macià F; Castells A;
    Med Clin (Barc); 2015 Aug; 145(4):141-6. PubMed ID: 25073826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Colorectal cancer screening].
    Castells A
    Gastroenterol Hepatol; 2013 Oct; 36 Suppl 2():66-72. PubMed ID: 24160954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Colorectal cancer screening programme in Aragon (Spain): preliminary results].
    Solé Llop ME; Cano Del Pozo M; García Montero JI; Carrera-Lasfuentes P; Lanas Á
    Gac Sanit; 2018; 32(6):559-562. PubMed ID: 28784304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Colorectal cancer screening: where are we and where are we going?].
    Fantin A; Chiarioni G
    Recenti Prog Med; 2013 Feb; 104(2):45-8. PubMed ID: 23535955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test.
    McNamara D; Leen R; Seng-Lee C; Shearer N; Crotty P; Neary P; Walsh P; Boran G; O'Morain C
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1415-21. PubMed ID: 25244415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; de Pretis G; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex DK; Zappa M; Hassan C;
    Gut; 2017 Jul; 66(7):1233-1240. PubMed ID: 26896459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples.
    Guittet L; Bouvier V; Mariotte N; Vallee JP; Levillain R; Tichet J; Launoy G
    Int J Cancer; 2009 Sep; 125(5):1127-33. PubMed ID: 19431212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year risk of colorectal neoplasia after negative screening colonoscopy.
    Imperiale TF; Glowinski EA; Lin-Cooper C; Larkin GN; Rogge JD; Ransohoff DF
    N Engl J Med; 2008 Sep; 359(12):1218-24. PubMed ID: 18799558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.
    Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M
    Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
    Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
    Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview.
    IJspeert JEG; Bevan R; Senore C; Kaminski MF; Kuipers EJ; Mroz A; Bessa X; Cassoni P; Hassan C; Repici A; Balaguer F; Rees CJ; Dekker E
    Gut; 2017 Jul; 66(7):1225-1232. PubMed ID: 26911398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Colonoscopies for colorectal cancer screening].
    Bessa Caserras X
    Gastroenterol Hepatol; 2014 Sep; 37 Suppl 3():85-92. PubMed ID: 25294270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colonoscopy quality control as a requirement of colorectal cancer screening].
    Quintero E; Alarcón-Fernández O; Jover R
    Gastroenterol Hepatol; 2013 Nov; 36(9):597-605. PubMed ID: 23769425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.